BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
June 1, 2009
View Archived Issues
Celldex Extending Pipeline, Cash Runway in $95M CuraGen Deal
Celldex Therapeutics Inc. took another step toward expanding its pipeline, agreeing to buy CuraGen Corp. in a $94.5 million stock deal that will bring in 11 drug candidates and some added cash. (BioWorld Today)
Read More
ASCO 2009 Kicks Off with Data in Hematologic Malignancies
Read More
Catalyst's Phase II Cocaine-Habit Failure Puts Squeeze on Finances
Read More
FDA Says Restrictive REMS Plan for Opioid Products Not Imminent
Read More
FDA Panel Backs Genmab's Arzerra in Refractory CLL
Read More
Other News To Note
Read More
Appointments And Advancements
Read More
Financings Roundup
Read More
Clinic Roundup
Read More